Home | Welcome to Contract Pharma   
Last Updated Tuesday, January 27 2015

Print RSS Feed

Breaking News

Related Searches:
April 14, 2011
Axcan has entered into an agreement to acquire Mpex Pharmaceuticals, Inc. and its lead product candidate, Aeroquin, a new aerosol formulation of levofloxacin.   Read More »
April 14, 2011
Watson Pharmaceuticals, Inc. has formally designated its Parsippany, NJ facility as its new corporate headquarters.   Read More »
April 13, 2011
West Pharmaceutical Services, Inc. is adding manufacturing capacity for the Daikyo Crystal Zenith 1mL syringe system for biopharmaceutical drug packaging and delivery.  Read More »
April 13, 2011
Amunix, Inc. has entered into an exclusive worldwide research collaboration with Biogen Idec to research and develop novel, fully-recombinant blood factors (Factors IX, VIII and VIIa) with improved therapeutic properties.  Read More »
April 13, 2011
Dimerix Bioscience Pty Ltd. has entered into a second research program with Takeda Cambridge Ltd., a UK based subsidiary of Takeda Pharmaceutical Co.  Read More »
April 13, 2011
Access Pharmaceuticals, Inc. has entered into an agreement with a major pharmaceutical company to use its CobaCyte and CobOral technology for the targeted delivery of RNAi therapeutics.   Read More »
April 12, 2011
Pieris AG has entered into a collaboration and license agreement with Daiichi Sankyo Co. Ltd., under which Pieris will apply its Anticalin scaffold technology to discover novel Anticalins against two Daiichi Sankyo targets.   Read More »
April 12, 2011
Novartis AG is discontinuing development of Tasigna as a treatment for cancerous tumors of the gastrointestinal tract.  Read More »
April 12, 2011
NSF-DBA has added five pharmaceutical experts to provide consulting and in-house training services to help companies comply with international regulations and improve quality management systems.  Read More »
April 12, 2011
Orasi Medical has entered into an agreement with Biogen Idec to test novel biomarkers for the development of treatments for central nervous system (CNS) disorders.  Read More »
April 11, 2011
Roche and Lonza have entered into a distribution agreement for the commercialization of Roche’s MycoTOOL mycoplasma PCR assays.   Read More »
April 11, 2011
Ken Jones has been appointed president and chief executive officer of Astellas Pharma Europe Ltd. (APEL), the European subsidiary Astellas Pharma, Inc.  Read More »
April 11, 2011
Merck & Co. and Sun Pharmaceutical Industries have created a joint venture to develop, manufacture and commercialize new combinations and formulations of branded generics in emerging markets.  Read More »
April 11, 2011
Biogen Idec achieved positive results from DEFINE, a Phase III trial to evaluate the investigational oral compound BG-12 (dimethyl fumarate) as a monotherapy in people with relapsing-remitting multiple sclerosis (RRMS).  Read More »
April 11, 2011
Johnson & Johnson received approval from the FDA for Invega (paliperidone) extended-release tablets for the treatment of schizophrenia in adolescents 12 to 17 years of age.  Read More »



Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On